4.5 Article

Cancer of the corpus uteri

Journal

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
Volume 119, Issue -, Pages S110-S117

Publisher

WILEY
DOI: 10.1016/S0020-7292(12)60024-1

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study

Emiel A. De Jaeghere, Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens, Peter Vuylsteke, Stephanie Henry, Xuan Bich Trinh, Peter A. van Dam, Sandrine Aspeslagh, Alex De Caluwe, Eline Naert, Diether Lambrechts, An Hendrix, Olivier De Wever, Koen K. Van de Vijver, Frederic Amant, Katrien Vandecasteele, Hannelore G. Denys

Summary: The PRIMMO study conducted a phase II trial on patients with pretreated persistent/recurrent/metastatic cervical or endometrial cancer. The study found that pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail had modest but durable antitumor activity, with acceptable but not negligible toxicity.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

Article Oncology

Ten-year experience of a national multidisciplinary tumour board for cancer and pregnancy in the Netherlands

Joosje H. Heimovaara, Ingrid A. Boere, Jorine de Haan, Kristel van Calsteren, Frederic Amant, Lia van Zuylen, Christine A. R. Lok

Summary: The Dutch multidisciplinary tumor board for cancer, infertility, and pregnancy (CIP-MDT) provides consultation services for physicians regarding cancer treatment during pregnancy and has achieved a high level of satisfaction. The study also identifies common types of cancer and consultation topics.

EUROPEAN JOURNAL OF CANCER (2022)

Review Surgery

An Algorithm for Labia Minora Reduction Based on a Review of Anatomical, Configurational, and Individual Considerations

Maurits Lange, J. Joris Hage, Refaat B. Karim, Frederic Amant

Summary: Various techniques have been introduced for reduction labiaplasty, but there is no single technique that is optimal for every patient. The choice of technique should be based on anatomical, configurational, and technical considerations, as well as the patient's personal preferences. An algorithm has been developed to guide the choice of technique, considering factors such as resection or retention of the labial free rim, required labial width reduction, labial vascular status, prevention of iatrogenic labial thickening, and preservation of labial sensibility. The choice of techniques includes edge trimming, central spindle form de-epithelialization or full-thickness resection, and modifications of the wedge resection or de-epithelialization technique.

ARCHIVES OF PLASTIC SURGERY-APS (2023)

Article Oncology

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

Lisa J. Vermij, Jan J. Jobsen, Alicia Leon-Castillo, Mariel Brinkhuis, Suzan E. Roothaan, Melanie E. M. Powell, Stephanie M. de Boer, Pearly R. Khaw, Linda R. Mileshkin, Anthony Fyles, Alexandra Leary, Catherine M. Genestie, Ina M. J. Jurgenliemk-Schulz, Emma J. J. Crosbie, Helen J. Mackay, Hans. W. A. Nijman, Remi A. Nout, Vincent T. H. B. M. L. Smit, Carien L. Creutzberg, Nanda Horeweg, Tjalling M. Bosse, Stephanie M. de Boer

Summary: This study aimed to investigate whether adding hormone receptor expression, L1CAM expression or CTNNB1 status can improve the accuracy of risk assessment in endometrial cancer (EC). The study found that the expression of ER, PR, L1CAM, and CTNNB1 did not have independent prognostic value in EC, while age, stage, and adjuvant chemotherapy had an independent impact on the risk of recurrence. However, in high-risk EC of non-serous/mixed papillary (NSMP) subgroup, ER positivity was independently associated with a reduced risk of recurrence.

BRITISH JOURNAL OF CANCER (2023)

Article Environmental Sciences

Characterization of the genotoxic profile of antineoplastic drugs using the cytokinesis-block micronucleus cytome assay

Ilana Struys, Eline Verscheure, Liesbeth Lenaerts, Frederic Amant, Lode Godderis, Manosij Ghosh

Summary: Due to the genotoxic consequences of antineoplastic agents on non-cancerous tissue, it is crucial to understand their effects. This study aimed to characterize the genotoxic profile of different classes of antineoplastic drugs using a cell line assay. The results showed increased micronucleus formation with all tested drugs, as well as specific abnormalities for each drug class. These findings can aid in interpreting genotoxic aberrations in patients treated with these drugs.

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2023)

Article Oncology

Psychological impact of referral to an oncology hospital on patients with an ovarian mass

Pien Lof, Ellen G. Engelhardt, Mignon D. J. M. van Gent, Constantijne H. Mom, Fleur M. F. Rosier-van Dunne, W. Marchien van Baal, Harold R. Verhoeve, Brenda B. J. Hermsen, Marjolijn B. Verbruggen, Majoie Hemelaar, Jojanneke M. G. van de Swaluw, Haye C. Knipscheer, Judith A. F. Huirne, Steven M. Westenberg, Willemien J. van Driel, Eveline M. A. Bleiker, Frederic Amant, Christianne A. R. Lok

Summary: This study evaluated cancer-specific distress and treatment satisfaction in patients with an ovarian mass. It found that many patients experienced high cancer-specific distress during the work-up process. However, patients were generally satisfied with their treatment regardless of the diagnosis and treatment location. This suggests that patients' preferences should be considered when developing risk assessment strategies.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

Article Oncology

Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program

T. Bosse, C. L. Creutzberg, E. J. Crosbie, K. Han, N. Horeweg, A. Leary, J. R. Kroep, J. N. McAlpine, M. E. Powell, F. Blanc-Durand, M. de Bruyn, D. N. Church, V. H. Koelzer, S. Kommoss, N. Singh, A. Bardet, N. Counsell, H. Putter, D. Tu, R. Edmondson, C. Gordon, J. Ledermann, P. Morice, H. MacKay, H. Nijman, R. A. Nout, V. T. H. B. M. Smit, H. White, J. Alexandre, S. M. de Boer, I Boere, R. Cooper, J. L. Ethier, J. S. Frenel, J. McGrane, A. Taylor, S. Welch, A. M. Westermann, H. Dijcker-van der Linden, L. Farrelly, A. Feeney, M. Kaya, W. Liu, A. Melis, F. Ngadjeua-Tchouatieu, W. Parulekar, K. Verhoeven-Adema, RAINBO Res Consortium

Summary: The RAINBO program aims to investigate molecular class-directed adjuvant treatment strategies for endometrial cancer, with the goal of improving clinical outcomes and reducing toxicity. It consists of four international clinical trials and an overarching research program to advance knowledge of predictive and prognostic markers.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

Review Oncology

A pregnant patient with ALK-positive non-small cell lung cancer treated with alectinib: A case report and review of the literature

Fabian De Smedt, Frederique Dessy, Luciano Carestia, Pamela Baldin, Frank Aboubakar Nana, Philippe Clapuyt, Veronique Boon, Frederic Amant, Mina Mhallem Gziri

Summary: Oncogenic rearrangements in the ALK gene are responsible for 5% of NSCLC cases, and ALK inhibitors have significantly improved the outcomes in ALK(+) mNSCLC patients. ALK(+) NSCLC accounts for 38% of cases in women of childbearing age, presenting new challenges in lung cancer and obstetrics research. This study reported a case of a pregnant HIV-infected patient with ALK(+) mNSCLC who had no fetal developmental abnormalities or obstetric complications during treatment with alectinib.

ONCOLOGY LETTERS (2023)

Article Orthopedics

Surgical flap delay to allow primary transabdominal transplantation of extended rectus abdominis myocutaneous flaps in increasingly complex pelvic wound reconstructions

Maurits Lange, J. Joris Hage, Arend Aalbers, Esther M. K. Wit, Frederic Amant, Marije J. Hoornweg

Summary: Primary intra- or transabdominal transplantation of extended rectus abdominis myocutaneous (ERAM) flap can prevent surgical complications. Delaying the flap can reduce the risk of intra-abdominal flap loss. However, it may lead to other complications.

JOURNAL OF PLASTIC SURGERY AND HAND SURGERY (2023)

Article Pharmacology & Pharmacy

Predicting Chemotherapy Distribution into Breast Milk for Breastfeeding Women Using a Population Pharmacokinetic Approach

David Damoiseaux, Daniel Centanni, Jos H. Beijnen, Frederic Amant, Alwin D. R. Huitema, Thomas P. C. Dorlo

Summary: Information on the distribution of chemotherapeutic drugs to breast milk is limited, and our study aimed to predict chemotherapy distribution in a more realistic breastfeeding population and evaluate the effect of discarding breast milk on potential chemotherapy exposure in infants.

CLINICAL PHARMACOKINETICS (2023)

Article Oncology

Vaginal changes, sexual functioning and distress of women with locally advanced cervical cancer treated in the EMBRACE vaginal morbidity substudy

I. Suvaal, K. Kirchheiner, R. A. Nout, A. E. Sturdza, E. Van Limbergen, J. C. Lindegaard, H. Putter, I. M. Jurgenliemk-Schulz, C. Chargari, K. Tanderup, R. Poetter, C. L. Creutzberg, M. M. ter Kuile

Summary: The study prospectively evaluated vaginal changes and patient-reported outcomes after image-guided radio(chemo)therapy and brachytherapy for locally advanced cervical cancer. Mild vaginal changes were reported, and a significant proportion of patients experienced vaginal and sexual functioning problems. However, the rate of substantial problems and distress was low, and there was no clear association between vaginal changes and sexual functioning problems.

GYNECOLOGIC ONCOLOGY (2023)

Article Oncology

Improving Endometrial cancer assessment by combining the new techniqUe of GENomic profiling with surgical Extra uterIne disEase assessment (EUGENIE)

Jenneke C. Kasius, Rita Trozzi, Johanna Pijnenborg, Thais Baert, Annouschka Laenen, Anne-Sophie Van Rompuy, Ignacio Zapardiel, Giuseppe Vizzielli, Jure Knez, Francesco Fanfani, Frederic Amant

Summary: The study aims to determine the association between molecular classification and disease stage in endometrial cancer, in order to guide surgical approach. 1000 female patients aged 18 or above will be enrolled, and results on staging and oncological outcomes are expected in 2027 and 2029 respectively.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

Article Oncology

Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRI

Sander Dumont, Vincent Vandecaveye, Raphaela Carmen Dresen, Els Van Nieuwenhuysen, Thais Baert, Frederic Amant, Valerie Broeckhoven, Toon Van Gorp

Summary: This study aimed to evaluate the diagnostic value of whole-body diffusion-weighted magnetic resonance imaging (WB-DWI/MRI) in predicting resectable disease during secondary cytoreductive surgery for relapsed epithelial ovarian cancer. The study found that WB-DWI/MRI accurately predicted resectable disease and was associated with improved progression-free and overall survival of the patients.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

Article Oncology

FIGO staging of endometrial cancer: 2023

Jonathan S. Berek, Xavier Matias-Guiu, Carien Creutzberg, Christina Fotopoulou, David Gaffney, Sean Kehoe, Kristina Lindemann, David Mutch, Endometrial Canc Staging Subcomm, FIGO Womens Canc Comm

Summary: Since the 2009 update of the FIGO staging system, there have been significant advances in understanding the pathologic and molecular features of endometrial cancer. The new staging system aims to better define prognostic groups and create substages to guide more appropriate treatment.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2023)

Article Obstetrics & Gynecology

Effects of chemotherapy on ovaries of pregnant mice

Teska Schuurman, Ji-Ying Song, Vera Wolters, Marieke van de Ven, Nienke van Trommel, Ina Beerendonk, Frederic Amant, Christianne Lok

Summary: This study found that chemotherapy can cause damage to the maternal ovaries during pregnancy, and the extent of this damage depends on the type of chemotherapy and the duration of exposure. Short-term exposure leads to more severe damage, but it might be temporary. Chemotherapy also results in the loss of primordial follicles and DNA damage, with paclitaxel causing the least damage.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2023)

No Data Available